Dealing With Anxiety in the Time of COVID-19
Now that we’re in the middle of a pandemic, more people than ever are experiencing anxiety, especially those who struggled with mental health issues before COVID-19. And to make things even worse, many of our coping mechanisms, like going to the gym or hanging out with friends, have been taken away. In today’s show, our host, Gabe Howard, talks with Dr. Jasleen Chhatwal, who helps explain why so many people are having anxiety symptoms and what we can do about it. We want to hear from you — Please fill out our listener survey by clicking the graphic below! SUBSCRIBE &REVIEW Guest information for ‘Managing Anxiety’ Podcast Episode Jasleen Chhatwal, MD, is Chief Medical Officer and Director of the Mood Disorders Program at Sierra Tucson, a premier residential behavioral health treatment center. Dr. Chhatwal also serves as Assistant Professor at the University of Arizona College of Medicine. Board certified in Psychiatry and Integrative Medicine, she is well versed in psychodynamic psychotherapy, cognitive behavior therapy, psychopharmacology, neuromodulation including ECT &rTMS, and various emerging modalities. Dr. Chhatwal is active in the mental health community, advocating for her patients, colleagues, and profession through elected positions with the Arizona Psychiatric Society and American Psychiatric Association. About The Psych Central Podcast Host Gabe Howard is an award-winning writer and speaker w...
We describe the most highly recommended generic and disease-specific PRO tools in SCD and discuss the challenges of incorporating them in clinical practice. EXPERT OPINION: PRO measures are essential to incorporate into SCD clinical trials either as primary or secondary outcomes. The use of PRO measures in SCD facilitates a patient-centered approach, which is likely to lead to improved outcomes. Significant challenges remain in adapting PRO tools to routine clinical use and in developing countries. PMID: 33034214 [PubMed - as supplied by publisher]
Authors: Sabet Sarvestani F, Azarpira N Abstract Heart and cerebral infarctions, as two important ischemic diseases, lead to the death of tissues due to inadequate blood supply and high mortality worldwide. These statuses are started via blockage of vessels and depletion of oxygen and nutrients which affected these areas. After reperfusion and restoration of oxygen supply, more severe injury was mediated by multifaceted cascades of inflammation and oxidative stress. microRNAs (miRNAs) as the regulator of biological and pathological pathways can adjust these conditions by interaction with their targets. Also, miRNAs...
Publication date: Available online 10 October 2020Source: American Journal of Kidney DiseasesAuthor(s): Shreeram Akilesh, Cynthia C. Nast, Michifumi Yamashita, Kammi Henriksen, Vivek Charu, Megan L. Troxell, Neeraja Kambham, Erika Bracamonte, Donald Houghton, Naila I. Ahmed, Chyi Chyi Chong, Bijin Thajudeen, Shehzad Rehman, Firas Khoury, Jonathan E. Zuckerman, Jeremy Gitomer, Parthassarathy C. Raguram, Shanza Mujeeb, Ulrike Schwarze, M. Brendan Shannon
Currently in fellowship doing bread/butter procedures (MBB, epidurals, PNB, few SCS/PNS trials, etc.) and just interviewed at a private practice spot where they do a lot of procedures that I will have not done any training in prior to graduating (e.g. IT pump, SI fusion, Vertiflex, Kypho, MILD, Discectomy, lots of SCS/PNS trials etc) and significant amount of "OR pain procedures" at a very busy practice seeing 30-40 pts/day - how many of you are commonly performing these procedures and are... private practice concern
Publication date: Available online 9 October 2020Source: Reumatología Clínica (English Edition)Author(s): Lina María Saldarriaga Rivera, Daniel Fernández Ávila, Wilson Bautista Molano, Daniel Jaramillo Arroyave, Alain Jasaf Bautista Ramírez, Adriana Díaz Maldonado, Jorge Hernán Izquierdo, Edwin Jáuregui, María Constanza Latorre Muñoz, Juan Pablo Restrepo, Juan Sebastián Segura Charry
CONCLUSION: The proposed PHARMAC criteria will give access to these important drugs to those people with T2DM who will likely benefit the most. PMID: 33032305 [PubMed - in process]
CONCLUSIONS: This single practice study showed total patient contact was similar over both sample periods, but most contact in 2020 was virtual. Further longitudinal multi-practice studies to confirm these findings and describe future consultation patterns are needed to inform general practice service delivery post-COVID-19. PMID: 33032304 [PubMed - in process]
Publication date: Available online 1 October 2020Source: Academic RadiologyAuthor(s): Neo Poyiadji, Chad Klochko, Jeff LaForce, Manuel L. Brown, Brent Griffith
Curious what people think with pandemic and lack of away rotations.
More News: Anxiety | Back Pain | Bipolar | Brain | Cardiology | Children | Cognitive Behavior Therapy | Computers | Coronavirus | COVID-19 | Depression | Diabetes | Education | Employment | Endocrinology | Environmental Health | Eyes | Genetics | Health Management | Heart | Heart Attack | Hospitals | Insurance | Insurers | Learning | Legislation | Lessons | Mania | Men | Neurology | Nurses | Nursing | Pain | Pandemics | Panic Disorder | Podcasts | Psychiatry | Psychology | Psychotherapy | Suicide | Training | Universities & Medical Training | Websites